Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | PTAFR | P25105 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL814257 | 0.98 | MEN1 (0.47) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL815193 | 0.98 | MEN1 (0.47) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL10109969 | 0.98 | MEN1 (0.47) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL17694672 | 0.98 | MEN1 (0.47) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL10631212 | 0.98 | MEN1 (0.47) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL4173315 | 0.96 | MEN1 (0.48) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL15686649 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL3230862 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL9841873 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 | |
| SCHEMBL14971389 | 0.94 | MEN1 (0.50) | MEN1KMT2AALDH1A1TDP1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-9012096-B2 | Long life lithium batteries with stabilized electrodes | UCHICAGO ARGONNE, LLC (US) | 2015-04-21 | — | — | US | claimed |
| US-7851092-B2 | Redox shuttles for overcharge protection of lithium batteries | U CHICAGO ARGONNE LLC (US) | 2010-12-14 | — | — | US | claimed |
| CN-101426792-A | Pyrazolopyrimidines as therapeutic agents | ABBOTT GMBH & CO KG (DE) | 2009-05-06 | — | — | CN | claimed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | claimed |
| WO-2006094069-A2 | NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | claimed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | claimed |
| JP-2157271-A | — | — | None | — | — | JP | disclosed |
| JP-52000285-A | — | — | None | — | — | JP | disclosed |
| US-12021226-B2 | Cathode materials for secondary batteries | UCHICAGO ARGONNE, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230382880-A1 | GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2023-11-30 | — | — | US | disclosed |
| US-20230382851-A1 | GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2023-11-30 | — | — | US | disclosed |
| EP-1094805-A1 | SUBSTITUTED OXYGEN ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000001381-A1 | SUBSTITUTED OXYGEN ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | LEUKOSITE, INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| CN-1014893-B | Preparation method of 1- (2-tetrahydrofuryl) -5-fluorouracil | DAGAMI CHEMICAL RESEARCH CENTE (JP) | 1991-11-27 | — | — | CN | disclosed |
| JP-H02157271-A | PREPARATION OF AROMATIC CARBON-CARBON BOND COMPOUND | DAITO KOEKI KK | 1990-06-18 | — | — | JP | disclosed |
| CN-85108855-A | The preparation method of 1-(2-tetrahydrofuran base)-5 FU 5 fluorouracil | — | 1986-09-24 | — | — | CN | disclosed |
| JP-S52285-A | PREPARATION OF N1 *22TETRAHYDROFURYL**55FLUOROURACIL | TAIHO YAKUHIN KOGYO KK | 1977-01-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382880-A1 | GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM | HSD17B10, HSD17B12, HSD17B14 | MEN1 1919/4885KMT2A 3505/4885ALDH1A1 300/4885 |
| US-20230382851-A1 | GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM | HSD17B10, HSD17B12, HSD17B14 | MEN1 1919/4885KMT2A 3505/4885ALDH1A1 300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.